Adaptive Phage Therapeutics Competitors and Similar CompaniesClear all
Adaptive Phage Therapeutics's competitors and similar companies include Right To Care, Spur Therapeutics, Acorda Therapeutics and Codiak Biosciences.
 Right To Care Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa. |  Spur Therapeutics Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies. |  Acorda Therapeutics Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | ||
Founding Date | Founding Date 2016 | Founding Date 2001 | Founding Date 2015 | Founding Date 1995 | Founding Date 2015 |
Type | Type Private | Type Private | Type Subsidiary | Type Public | Type Public |
Tags | |||||
Locations | Locations Gaithersburg, US HQ Gaithersburg, US | Locations Stevenage, GB HQ Boston, US New York, US | Locations Ardsley, US HQ Chelsea, US South San Francisco, US Waltham, US | Locations Cambridge, US HQ | |
Employees | Employees 244% decrease | Employees 1,817 | Employees 122 | Employees 4742% decrease | Employees 992% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) N/A | Valuation ($) 821 k | Valuation ($) 2.8 m |
Financial | |||||
Revenue (est.) | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) N/A | Revenue (est.) $117.6m (FY, 2023) | Revenue (est.) $22.9m (FY, 2021) |
Cost of goods | Cost of goods N/A | Cost of goods N/A | Cost of goods N/A | Cost of goods $15.3m (FY, 2023) | Cost of goods N/A |
Net income | Net income N/A | Net income N/A | Net income ($89m) (FY, 2022) | Net income ($252.9m) (FY, 2023) | Net income ($37.2m) (FY, 2021) |
Funding | |||||
Total funding raised | Total funding raised $ 20.3m | Total funding raised N/A | Total funding raised $ 289.3m | Total funding raised N/A | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Right To Care
HQ
Centurion, ZA
Employees
1,817
Right To Care is a non-profit organization that supports and delivers prevention, care, and treatment for HIV and associated diseases in South Africa.
View companySpur Therapeutics
HQ
Stevenage, GB
Spur Therapeutics (formerly known as Freeline) is a clinical-stage biotechnology company that develops transformative gene therapies.
View companyAcorda Therapeutics
HQ
Ardsley, US
Employees
474↓ 2% decrease
Acorda Therapeutics is a biotechnology company focused on developing therapies that restore function and improve the lives of people with neurological disorders.
View companyCodiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company